AXL mediates resistance to cetuximab therapy
Brand, Toni M, Iida, Mari, Stein, Andrew P, Corrigan, Kelsey L, Braverman, Cara M, Luthar, Neha, Toulany, Mahmoud, Gill, Parkash S, Salgia, Ravi, Kimple, Randall J, Wheeler, Deric L
Published in Cancer research (Chicago, Ill.) (15.09.2014)
Published in Cancer research (Chicago, Ill.) (15.09.2014)
Get full text
Journal Article
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Brand, Toni M, Iida, Mari, Stein, Andrew P, Corrigan, Kelsey L, Braverman, Cara M, Coan, John P, Pearson, Hannah E, Bahrar, Harsh, Fowler, Tyler L, Bednarz, Bryan P, Saha, Sandeep, Yang, David, Gill, Parkash S, Lingen, Mark W, Saloura, Vassiliki, Villaflor, Victoria M, Salgia, Ravi, Kimple, Randall J, Wheeler, Deric L
Published in Clinical cancer research (01.06.2015)
Published in Clinical cancer research (01.06.2015)
Get full text
Journal Article
Correction: AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma
Brand, Toni M, Iida, Mari, Stein, Andrew P, Corrigan, Kelsey L, Braverman, Cara M, Coan, John P, Pearson, Hannah E, Bahrar, Harsh, Fowler, Tyler L, Bednarz, Bryan P, Saha, Sandeep, Yang, David, Gill, Parkash S, Lingen, Mark W, Saloura, Vassiliki, Villaflor, Victoria M, Salgia, Ravi, Kimple, Randall J, Wheeler, Deric L
Published in Clinical cancer research (01.12.2018)
Published in Clinical cancer research (01.12.2018)
Get full text
Journal Article
Abstract 3333: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
Brand, Toni M., Iida, Mari, Corrigan, Kelsey L., Braverman, Cara M., Coan, John P., Flanigan, Bailey G., Stein, Andrew P., Salgia, Ravi, Rolff, Jana, Kimple, Randall J., Wheeler, Deric L.
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article